SeaX Ventures taps healthcare veteran for biotech push

Tech in Asia· June 21, 2026

SeaX Ventures has appointed a healthcare industry veteran to spearhead its strategic expansion into the biotechnology sector. This leadership move signals the venture capital firm's intent to deepen its footprint in life sciences and specialized medical technologies. For the Healthcare & Biotech sector, this development indicates increasing capital interest and a shift toward expert-led investment strategies within the Southeast Asian venture landscape.

Read the full story at Tech in Asia

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to Tech in Asia.

More in Healthcare & Biotech

Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week

Biotech Showcase™ 2026 highlighted early-stage innovations within the biotechnology sector during the annual JPM Healthcare Week. The event serves as a critical platform for emerging companies to present their advancements to potential investors and strategic partners. This gathering underscores the ongoing focus on early-stage development as a driver for future growth in the healthcare and biotech industries.

June 22, 2026

European Commission Proposes New Measures to Bolster Biotech Innovation and Healthcare Resilience

The European Commission has introduced a comprehensive set of measures designed to modernize the European Union's healthcare sector and enhance its global competitiveness. Central to the proposal is a new Biotech Act aimed at accelerating clinical trial approvals and the development of advanced therapies while reducing regulatory costs for companies. These initiatives, which also include a dedicated plan for cardiovascular disease and streamlined medical device regulations, represent a significant effort to improve patient outcomes and ensure the long-term stability of the region's health industry.

June 22, 2026

Biotech Healthcare secures EU MDR certification for ophthalmic and medical devices

Biotech Healthcare has successfully obtained EU Medical Device Regulation (MDR) certification for its portfolio of ophthalmic and medical devices. This regulatory milestone ensures the company's products meet the stringent safety and performance standards required for the European market. For the healthcare and biotech sector, this certification is critical as it allows for continued commercialization and patient access to specialized eye care technologies under the updated EU regulatory framework.

June 20, 2026

What to Know: AI-Powered Healthcare Innovations Shine at Edison Awards

The Edison Awards recently highlighted several AI-powered healthcare innovations, showcasing the growing role of artificial intelligence in medical technology. These awards recognize excellence in new product and service development, marketing, and human-centered design. For the healthcare and biotech sector, these recognitions signal a shift toward more integrated, data-driven solutions aimed at improving patient outcomes and operational efficiency.

June 20, 2026